Skip to content

Lovick Edward Cannon, PhD

President and CEO at NovAb.

Earliest Form D on file: Apr 2026

Filed Apr 16, 2026

NovAb

Lamprey-derived antibodies for myeloma and autoimmunity

Biotech, Tucker GA

Signed as President and CEO

$65K

sold of $250K offered

Form D

LinkedIn

Network

At NovAb

2 people